Position in BMY
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$2,439,861
-$1,362 QoQ
Shares Held
42,344
+5.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#760
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. BMY ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,439,861 | 42,344 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $2,441,223 | 40,251 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,060,508 | 38,200 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $1,771,077 | 39,270 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,698,843 | 36,700 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,093,664 | 34,328 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,725,249 | 30,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,426,471 | 27,570 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $1,044,811 | 25,158 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,442,897 | 26,607 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,207,170 | 23,527 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,362,837 | 23,481 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,517,277 | 23,726 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $1,547,207 | 22,323 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,427,488 | 19,840 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,345,093 | 18,921 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,314,313 | 17,069 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,271,452 | 17,410 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $997,288 | 15,995 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $928,436 | 15,691 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,074,131 | 16,075 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,222,575 | 19,366 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $1,178,011 | 18,991 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,209,658 | 20,064 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,175,941 | 19,999 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $960,511 | 17,232 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||